Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 17 pseudogene 2 (KRT17P2) is a human pseudogene locus, meaning it shares sequence homology with the functionally active keratin 17 gene, but is not transcribed into a functional protein and does not participate in cellular processes. Unlike keratin 17, which is important for epithelial biology and pathogenesis of several skin disorders, the pseudogene has no demonstrated physiological or pathological role. It is annotated in genome databases solely for reference in evolutionary studies and genomic architecture[2][4].\n\nIf you intended to refer to the functional protein "Keratin 17" (KRT17), that gene is a type I intermediate filament involved in skin structure and several diseases, but "KRT17P2" only refers to its pseudogene, with no active role in biology or therapeutics[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 17 pseudogene 2 (KRT17P2).